A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

RECRUITING

New York, New York, New York

RECRUITING

New York, New York, New York

RECRUITING

Wilmington, North Carolina, Wilmington

COMPLETED

Miami, Florida, Miami

RECRUITING

Tampa, Florida, Tampa

RECRUITING

Bowling Green, Kentucky, Bowling Green

RECRUITING

Bexley, Ohio, Bexley

RECRUITING

Mayfield Heights, Ohio, Mayfield Heights

RECRUITING

Clinical Trials, Canton

RECRUITING

Mason, Ohio, Mason

COMPLETED

Clarksville, Indiana, Clarksville

COMPLETED

Troy, Michigan, Troy

COMPLETED

Warren, Michigan, Warren

COMPLETED

Hot Springs, Arkansas, Hot Springs

RECRUITING

Fayetteville, Arkansas, Fayetteville

COMPLETED

Frisco, Texas, Frisco

RECRUITING

Houston, Texas, Houston

COMPLETED

San Antonio, Texas, San Antonio

COMPLETED

Austin, Texas, Austin

RECRUITING

Jordan, Utah, Jordan

COMPLETED

Scottsdale, Arizona, Scottsdale

COMPLETED

Lomita, California, Lomita

RECRUITING

Encinitas, California, Encinitas

RECRUITING

Fountain Valley, California, Fountain Valley

COMPLETED

Portland, Oregon, Portland

RECRUITING

Spokane, Washington, Spokane

RECRUITING

New Haven, Connecticut, New Haven

RECRUITING

Burlington, Massachusetts, Burlington

NOT_YET_RECRUITING

Clinical Trials, Calgary

RECRUITING

Clinical Trials, Winnipeg

RECRUITING

Clinical Trials, Oakville

NOT_YET_RECRUITING

Clinical Trials, Peterborough

RECRUITING

Clinical Trials, Waterloo